SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare informs about press release

05 May 2025 Evaluate
Remedium Lifecare has informed that it enclosed a copy of the press release from the Company titled ‘Remedium Lifecare Rights Issue Gains Momentum: 26% Subscribed Within First Two Days’. This information will also be hosted on the Company’s website, at www.remlife.com.

The above information is a part of company’s filings submitted to BSE.

Supha Pharmachem Share Price

0.46 0.00 (0.00%)
27-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 215.90
Adani Enterprises 2404.05
Amrapali Industries 18.00
Rashi Peripheral 458.60
PDS 274.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×